Table 2.

Distribution of measurable and non-measurable lesions on baseline PET-CT

	Metastatic sites	Measurable lesions	Non-measurable lesions
Total No	59	44	38
Liver	17	27	5
Lung	6	1	5
Lymph Nodes	20	7	18
Peritoneal	11	7	7
Others	5	2	3